Pliant Therapeutics Inc (PLRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $43.21M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 28.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 21.2, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PLRX
News
PLRX Valuation
- P/B
- 0.3x
PLRX Profitability: Margins, ROIC and FCF
Pliant Therapeutics (PLRX) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -50.3%
Pliant Therapeutics Competitors
The companies most similar to Pliant Therapeutics (PLRX) include Pelthos Therapeutics, Plus Therapeutics and Gain Therapeutics.
Sector: Healthcare
Companies most similar to Pliant TherapeuticsPLRX Analyst Ratings
Pliant Therapeutics (PLRX) has a Sell consensus from 4 analysts: 0 Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell.
- Consensus
- Sell
- Analysts
- 4
- Strong Buy
- 0
- Buy
- 0
- Hold
- 3
- Sell
- 0
- Strong Sell
- 1
PLRX Bull Case vs Bear Case
Bear case
- PLRX's quarterly revenue changed -100.0% year over year.
PLRX Earnings: Beat Rate and Next Report
Pliant Therapeutics (PLRX) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 9, 2027.
- Beat rate
- 4 of 8 quarters (50.0%)
- Average surprise
- 0.7%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.38
PLRX Earnings Date
PLRX reports Mar 9, 2027. The date is estimated.
PLRX ETF Holders
GNG tracks 3 ETFs that hold PLRX. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Health Care Index Fund ETF Shares (VHT), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PLRX
When does PLRX report earnings?
Pliant Therapeutics Inc (PLRX) is expected to report earnings on Mar 9, 2027.
Does PLRX pay dividends?
Pliant Therapeutics Inc (PLRX) does not currently pay a regular dividend.
What is PLRX's market cap?
Pliant Therapeutics Inc (PLRX) has a market capitalization of $43.21M with a current stock price of $0.69.
PLRX pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.